128 related articles for article (PubMed ID: 36075285)
41. Lymphatic invasion in acral and non-acral melanoma: a comparative, clinicoprognostic study of primary cutaneous melanoma according to tumour site.
Jung JM; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Pathology; 2020 Oct; 52(6):670-675. PubMed ID: 32819739
[TBL] [Abstract][Full Text] [Related]
42. Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications.
Esmaeli B; Rubin ML; Xu S; Goepfert RP; Curry JL; Prieto VG; Ning J; Tetzlaff MT
Am J Surg Pathol; 2019 Dec; 43(12):1701-1710. PubMed ID: 31425167
[TBL] [Abstract][Full Text] [Related]
43. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
[TBL] [Abstract][Full Text] [Related]
44. [Clinical features and prognosis of cutaneous melanoma].
Tian Y; Li MW; Liu QK; Kang H
Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1146-1154. PubMed ID: 36319462
[No Abstract] [Full Text] [Related]
45. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
46. Cellular cohesion as a prognostic factor in malignant melanoma: a retrospective study with up to 12 years follow-up.
Roxanis I; Chow J
Mod Pathol; 2010 Apr; 23(4):502-10. PubMed ID: 20173731
[TBL] [Abstract][Full Text] [Related]
47. Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians.
Carrera C; Gual A; Díaz A; Puig-Butillé JA; Noguès S; Vilalta A; Conill C; Rull R; Vilana R; Arguis P; Vidal-Sicart S; Alós L; Palou J; Castel T; Malvehy J; Puig S
Melanoma Res; 2017 Aug; 27(4):315-320. PubMed ID: 28296711
[TBL] [Abstract][Full Text] [Related]
48. Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients.
Drepper H; Köhler CO; Bastian B; Breuninger H; Bröcker EB; Göhl J; Groth W; Hermanek P; Hohenberger W; Lippold A
Cancer; 1993 Aug; 72(3):741-9. PubMed ID: 8334626
[TBL] [Abstract][Full Text] [Related]
49. A single institute's experience on melanoma prognosis: a long-term follow-up.
Dika E; Chessa MA; Veronesi G; Ravaioli GM; Fanti PA; Ribero S; Tripepi G; Gurioli C; Traniello Gradassi A; Lambertini M; Patrizi A
G Ital Dermatol Venereol; 2018 Jun; 153(3):326-332. PubMed ID: 28079338
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors in young women with cutaneous melanoma.
Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma.
Stiegel E; Xiong D; Ya J; Funchain P; Isakov R; Gastman B; Vij A
J Am Acad Dermatol; 2018 May; 78(5):942-948. PubMed ID: 29408526
[TBL] [Abstract][Full Text] [Related]
52. Soluble interleukin-2 receptor in stage I-III melanoma.
Ottaiano A; Leonardi E; Simeone E; Ascierto PA; Scala S; Calemma R; Bryce J; Caracò C; Satriano RA; Gianfranco N; Franco R; Botti G; Castello G
Cytokine; 2006 Feb; 33(3):150-5. PubMed ID: 16517174
[TBL] [Abstract][Full Text] [Related]
53. Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.
Dessinioti C; Dimou N; Geller AC; Stergiopoulou A; Lo S; Keim U; Gershenwald JE; Haydu LE; Ribero S; Quaglino P; Puig S; Malvehy J; Kandolf-Sekulovic L; Radevic T; Kaufmann R; Meister L; Nagore E; Traves V; Champsas GG; Plaka M; Dreno B; Varey E; Ramirez DM; Dummer R; Mangana J; Hauschild A; Egberts F; Peris K; Del Regno L; Forsea AM; Zurac SA; Vieira R; Brinca A; Zalaudek I; Deinlein T; Linos E; Evangelou E; Thompson JF; Scolyer RA; Garbe C; Stratigos AJ
J Natl Cancer Inst; 2019 Dec; 111(12):1314-1322. PubMed ID: 30863861
[TBL] [Abstract][Full Text] [Related]
54. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
55. Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma.
Calomarde-Rees L; García-Calatayud R; Requena Caballero C; Manrique-Silva E; Traves V; García-Casado Z; Soriano V; Kumar R; Nagore E
JAMA Dermatol; 2019 Jun; 155(6):679-687. PubMed ID: 31042264
[TBL] [Abstract][Full Text] [Related]
56. Survival rates for invasive cutaneous malignant melanoma in South Korea in accordance with the Eighth edition AJCC Cancer Staging Manual: A retrospective single center study.
Hwa Lee S; Ung Ha G; Ji Lee H; Yun Chung H; Huh S; Ha DL; Duck Park K; Hyun Jang Y; Ju Lee W; Lee SJ; Young Kim J
Indian J Dermatol Venereol Leprol; 2023 May; ():1-7. PubMed ID: 37317716
[TBL] [Abstract][Full Text] [Related]
57. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathological characteristics and prognosis of amelanotic acral melanoma: A comparative study with pigmented acral melanoma.
Gong HZ; Zheng HY; Li J
Australas J Dermatol; 2020 Nov; 61(4):358-361. PubMed ID: 32424819
[TBL] [Abstract][Full Text] [Related]
59. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.
El Sharouni MA; Aivazian K; Witkamp AJ; Sigurdsson V; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
JAMA Dermatol; 2021 Feb; 157(2):166-173. PubMed ID: 33355600
[TBL] [Abstract][Full Text] [Related]
60. [Sentinel lymph node biopsy in patients with melanoma].
Tomás-Mallebrera L; Rojo-España R; Marquina-Vila A; Gimeno-Clemente N; Morales-Suárez-Varela MM
Actas Dermosifiliogr; 2010 Jun; 101(5):428-36. PubMed ID: 20525486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
